Genoimmune Therapeutics
Wuhan
About Genoimmune Therapeutics
Genoimmune Therapeutics is a holding subsidiary of Shenzhen Huada Gene Technology Co., Ltd. It is a high-tech biotechnology enterprise dedicated to the treatment of tumor immune cells. Through the use of advanced life digital technology, the human immune system can be fully stimulated against the tumor, and new advanced prevention and treatment programs targeting tumor-specific antigens can be developed to benefit patients. Since 2011, he has focused on the development of tumor genomes, bioinformatics and tumor immunity.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $17.9M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2019)
- Website: genoimmune.genomics.cn
- Phone: +86 755-36352085
Industries & Categories
Biotechnology, Therapeutics
Canonical: https://fsome.com/organization/genoimmune-therapeutics-10598 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.